Method for enhancing or inhibiting insulin-Like Growth Factor-I

David R. Clemmons (Inventor), Laura A. Maile (Inventor)

Research output: Patent

Abstract

The present invention provides .alpha.V.beta.3 integrin cysteine loop domain agonists and antagonists (including peptide agonists and antagonists and analogs thereof), along with methods of using the same.
LanguageEnglish
Patent number7723483
IPCC07K 16/00 (20060101)
StatePublished - 1800

Fingerprint

Insulin-Like Growth Factor I
Integrins
Cysteine
Peptides

Keywords

    Cite this

    Clemmons, D. R., & Maile, L. A. (1800). IPC No. C07K 16/00 (20060101). Method for enhancing or inhibiting insulin-Like Growth Factor-I (Patent No. 7723483.)

    Method for enhancing or inhibiting insulin-Like Growth Factor-I. / Clemmons, David R. (Inventor); Maile, Laura A. (Inventor).

    IPC No.: C07K 16/00 (20060101). Patent No.: 7723483.

    Research output: Patent

    Clemmons, DR & Maile, LA 1800, Method for enhancing or inhibiting insulin-Like Growth Factor-I, Patent No. 7723483, IPC No. C07K 16/00 (20060101).
    Clemmons DR, Maile LA, inventors. Method for enhancing or inhibiting insulin-Like Growth Factor-I. C07K 16/00 (20060101). 1800
    Clemmons, David R. (Inventor) ; Maile, Laura A. (Inventor). / Method for enhancing or inhibiting insulin-Like Growth Factor-I. IPC No.: C07K 16/00 (20060101). Patent No.: 7723483.
    @misc{80bd49288ada4b5094586140052c9be2,
    title = "Method for enhancing or inhibiting insulin-Like Growth Factor-I",
    abstract = "The present invention provides .alpha.V.beta.3 integrin cysteine loop domain agonists and antagonists (including peptide agonists and antagonists and analogs thereof), along with methods of using the same.",
    keywords = "2333/65 (20130101); G01N 2333/70557 (20130101); G01N 2500/04 (20130101)",
    author = "Clemmons, {David R.} and Maile, {Laura A.}",
    note = "Status: published applicationnumber: 11/123,290 usclass: 530/387.1 ; 530/388.1 applicationnumber: 11/123,290; 7723483; C07K 16/00 (20060101)",
    year = "1800",
    language = "English",
    type = "Patent",

    }

    TY - PAT

    T1 - Method for enhancing or inhibiting insulin-Like Growth Factor-I

    AU - Clemmons,David R.

    AU - Maile,Laura A.

    N1 - Status: published applicationnumber: 11/123,290 usclass: 530/387.1 ; 530/388.1 applicationnumber: 11/123,290

    PY - 1800

    Y1 - 1800

    N2 - The present invention provides .alpha.V.beta.3 integrin cysteine loop domain agonists and antagonists (including peptide agonists and antagonists and analogs thereof), along with methods of using the same.

    AB - The present invention provides .alpha.V.beta.3 integrin cysteine loop domain agonists and antagonists (including peptide agonists and antagonists and analogs thereof), along with methods of using the same.

    KW - 2333/65 (20130101); G01N 2333/70557 (20130101); G01N 2500/04 (20130101)

    M3 - Patent

    M1 - 7723483

    ER -